Clinical Trial Update: Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating regional cryotherapy to prevent paclitaxel-induced peripheral neuropathy in breast cancer patients; status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxol (paclitaxel)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN